gunnerg does not lie.

I said the partnership no longer shows H1.  Nice try.
Also, slide 6 makes no mention whatsoever of partnership of Ryplazim.

As someone else pointed out, Ryplazim approval has now been pushed out to 2021.  OMG

Everyone is looking at the February 2020 presentation on the Liminal website.  Once again you fail to comprehend my post and the Liminal presentation, the current presentation.

You need to read everything, three times, slowly, and then not post a response.  You never make any sense.

 

realstocky wrote:

 

slide 11 tells you riplazym BLA is H1 2020 as expected, slide 6 shows you riplazym partnership comes before BLA/FDA ok, as always said.  (((makes logical sense as u want to be ready to go at launch, having the distribution channels etc )))
 

https://resources.liminalbiosciences.com/latest-content/lmnl-corporate-presentation-february-2020